Trial Comparing Metformin Versus Placebo in Non Alcoholic Steatohepatitis (NASH) Patients Receiving Bariatric Surgery for Obesity

• Status: Unknown status
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a comparison of metformin versus placebo in NASH patients receiving bariatric surgery for obesity.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Ghent
• Collaborator: Merck Sharp & Dohme Corp.
• Treatments: Metformin

Criteria

Inclusion Criteria:

• Patients receiving bariatric surgery for obesity

Exclusion Criteria:

• Other causes of liver disease (hepatitis B virus [HBV], hepatitis C virus [HCV], primary biliary cirrhosis [PBC], etc.)

• Patients with diabetes type I

• Patients with endocrinological reasons for obesity (eg. Cushing, etc.)